Praj Industries Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/x2c3fn8qsg5svoqz6hmzhk9v.pdf

Key Takeaways


Margin & Revenue Mix

Joshipura: "when we issued the guideline of 10,000 crores, that is 3x growth in topline and 5x in bottom line by 2030. That is intact and that's not changing. We are very confident and committed that that will happen as a company, as a team. There is absolutely no reason for us to believe that there is any other story."

GenX Facility & Engineering Business


CBG: Ecosystem, Co-Products & New Models

Joshipura: "India is not a gas or was not a gas economy. We were more a liquid and solid fuel economy. So, the whole infrastructure development, the rules and regulations, the last mile connectivity, a number of issues that have to be taken care of. And I think that's being addressed expeditiously by all concerned. But yes, we are not ready."

Bioenergy: Ethanol, SAF & 2G

Joshipura: "there is a slight delay from the initial plan for the SAF producers in the United States, but all of them are going ahead with their projects. There's nobody shelving, the opportunity very much exists. And I think the delay is behind us now. So, as we go through the next 18 months, you will actually see this coming to fruition as concrete projects."

International Business & Other Verticals

Joshipura: "We are not saying that this international business growth comes at the expense of domestic business volumes. What we are saying is that as we grow, we expect the international business to grow at a much faster pace compared to where it is today."

Bioplastics & Emerging Technologies


Guidance & Commitments

CommitmentSpecificsTimeline
Long-term growth target3x topline (₹10,000 crore) and 5x bottom-lineBy 2030
Domestic/international revenue mix50% domestic, 50% internationalBy 2030
International revenue target₹5,000 crore (8x from FY24 base of ₹665 crore)By FY30
GenX facility revenue startRevenue from GenX orders to begin flowingH2 FY26
CBG project commissioningFour projects under construction to enter commissioningQ1 next year
BPCL/IOCL JV definitive agreementDefinitive JV agreement with capital structure and commitmentsNext 3–4 months
Bio-bitumen market detailManagement to provide more detail on bio-bitumen potentialIn three months
Engineering order trajectoryProportion of engineering orders to be higher than current quarter exit rateNext year
2G projects in IndiaTwo additional 2G projects to go on streamDuring this calendar year
US SAF concrete projectsSAF projects to come to fruition as concrete projectsOver the next 18 months
Brewery capacity creationMovement in brewery business to strengthenNext financial year

Key Metrics

MetricQ3 FY25
Consolidated income from operations₹853 cr, compared to ₹828 cr in Q3 FY24
Profit before tax₹58.8 cr, compared to ₹91.9 cr in Q3 FY24
Profit after tax₹41.1 cr, compared to ₹70.4 cr in Q3 FY24
9M FY25 income from operations₹2,370 cr, compared to ₹2,440 cr in 9M FY24
9M FY25 PBT₹210 cr, compared to ₹250 cr in 9M FY24
9M FY25 PAT₹180 cr, compared to ₹190 cr in 9M FY24
9M FY25 marginHigher by 500 bps compared to 9M FY24
Export revenue share21% of total revenue in Q3
Revenue mix73% bioenergy, 18% engineering, 9% PHS
Order intake₹1,050 cr, 60% domestic
Order backlog₹4,350 cr as of Dec 24, 75% domestic
International order book share40%, highest over the last three quarters
Cash in hand₹640 cr as of Dec 31
Service business 9M FY25 order book80% higher than entire FY24
Mangalore facility total CAPEXOver ₹200 cr
Mangalore facility YTD operating expensesAlmost ₹80 cr